In this inaugural Daffodil Centre Flagship Seminar, you will hear from the leading international cancer researchers investigating the 'secondary' impacts of the COVID-19 pandemic on cancer prevention, screening and treatment. With representation across 38 countries, the COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis.
Hosted by Professor Karen Canfell, Director of the Daffodil Centre and Co-Chair of the CCGMC, the Flagship Seminar series will be formally launched by Dr Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC) with an opening address on IARC’s mission and collaboration with the Daffodil Centre.
Join us to hear about the CCGMC’s current research and emerging results from leading members of this global research consortium, including:
Overview of the COVID-19 and Cancer Global Modelling Consortium (CCGMC)
Dr Freddie Bray, IARC, Co-Chair CCGMC
Impact on cancer risk: worldwide review of smoking behavioural changes during the pandemic
Dr Isabelle Soerjomataram, IARC
Dr Peter Sarich, the Daffodil Centre
Impact of disruptions on cancer screening programs using the example of colorectal cancer screening
Dr Iris Lansdorp-Vogelaar, Erasmus University, The Netherlands
Dr Eleonora Feletto, the Daffodil Centre
Review of the impact of COVID-19 on cancer outcomes, and the projected impact of treatment disruptions in Canada
Dr Julia Steinberg, the Daffodil Centre
Dr Talia Malagon, McGill University, Canada
Cervical cancer elimination: the impact of COVID-19 on reaching the WHO global targets
Professor Karen Canfell, the Daffodil Centre
Dr Kate Simms, the Daffodil Centre
Moderated Q&A: What are the implications for cancer control in Australia?